Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Sodium Carbonate | HCID 10340 | — |
| Reactant | 4-tert-Butylphenylboronic acid | HCID 2734320 | — |
| Reactant | 2-Dicyclohexylphosphino-2',4',6'-triisoprophylbiphenyl | HCID 11155794 | — |
| Reactant | 6-chloro-N-(6-(2-methylpyrrolidin-1-yl)pyridin-2-yl)imidazo[1,2-b]pyridazin-8-amine | HCID 71534384 | — |
| Catalyst | (1E,4E)-1,5-diphenylpenta-1,4-dien-3-one; palladium | HCID 6505921 | — |
| Solvent | 1,4-Dioxane--water (1/1) | HCID 21886435 | — |
| Product | HCID 71526618 | HCID 71526618 | 38.4% |
Reaction Steps
To a solution of 6-chloro-N-(6-(2-methylpyrrolidin-1-yl)pyridin-2-yl)imidazo[1,2-b]pyridazin-8-amine (60 mg, 0.183 mmol) and 4-tert-butylphenylboronic acid (49 mg, 0.274 mmol) in dioxane/H2O (10 mL/1 mL) was added Na2CO3 (39 mg, 0.366 mmol) followed by Pd(dba)2 (21 mg) and X-Phos (9 mg) under nitrogen with stirring. The mixture was refluxed for 15 h under nitrogen. After cooling, the solvent was concentrated in vacuo. The residue was purified by chromatography (silica, dichloromethane:MeOH=100:1) to give 6-(4-tert-butylphenyl)-N-(6-(2-methylpyrrolidin-1-yl)pyridin-2-yl)imidazo[1,2-b]pyri-dazin-8-amine (30 mg, 38%) as a solid. 1H NMR (300 MHz, CDCl3): δ 8.70 (s, 1H), 8.30 (brs, 1H), 7.90 (d, 1H, J=7.5 Hz), 7.60 (s, 1H), 7.51-7.38 (m, 4 h), 6.31 (d, 1H, J=7.2 Hz), 6.03 (d, 1H, J=8.1 Hz), 4.24 (brs, 1H), 3.66 (brs, 1H), 3.49-3.47 (m, 1H), 2.15-2.09 (m, 3H), 1.75 (brs, 1H), 1.38 (s, 9H), 1.23 (d, 3H, J=6.3 Hz). LC/MS: 427 [M+H]+, tR=2.51 min. HPLC: 95.63% at 214 nm, 99.19% at 254 nm, tR=99.79% min.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09169259B2 |
|---|
| Source dataset | uspto-grants-2015_10 |
|---|
| ORD ID | ord-d7b1a5a0b5194ad39fd21e1e7c49b0d7 |
|---|
| Source note | uspto-grants-2015_10 |
|---|